Skip to main content

Table 2 Trial schedule of enrollment, interventions, and data assessments

From: Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study

Time point

Screening

Period of adjuvant chemotherapy

Follow-up, months

−4–0 week

1

3

6

9

12

…

36

Enrollment

 Informed consent

X

       

 Eligibility screen

X

       

General assessment

 Demographic data

X

       

 Medical history

X

       

 Treatment situation

X

       

TCM program

 CHM intervention

 

X

X

X

    

 TCM cohort only

X

X

X

X

X

X

X

X

 Assessment

  FACT-B

X

 

X

X

    

  ECOG

X

 

X

X

    

  BCQ

X

  

X

    

  MEAD

X

  

X

    

Imaging examination (CT, type B ultrasonography, bone scan)

X

 

X

X

X

X

X

X

Tumor markers (CEA & CA15-3)

X

 

X

X

X

X

X

X

Safety indicators

X

X

X

X

X

X

X

X

Chemotherapy-induced side effect, CTCAE

 

X

X

X

X

X

X

X

Cohort migration

    

X

X

X

X

Combined medication

    

X

   
  1. ECOG Eastern Cooperative Oncology Group, FACT-B Functional Assessment of Cancer Therapy-B, BCQ Body Constitution Questionnaire, MEAD Meridian Energy Analysis Device, CT Computed tomography, CEA Carcinoembryonic antigen, CA15-3 Cancer antigen 15-3, CTCAE Common Terminology Criteria for Adverse Events, CHM Chinese herbal medicine, TCM Traditional Chinese medicine
Back to article page

Trials

ISSN: 1745-6215